Urban Supreme System

"Chairman Zhan, let's take our leave first." Since there was no result now, Su Zhe proposed to leave.

"Okay, Mr. Su, see you next time. I will try my best to give your company an answer." Zhan Xin stepped forward and said.

Zhan Xin didn't walk back until he was sent to the gate of Guanzhou Xinjing Pharmaceutical.

On the way back, Liu Xiong said, "How much time should we give Guanzhou Xinjing Pharmaceutical?"

Su Zhe, who was sitting in the back seat, thought for a while and then said: "In three days, if there is no reply from Guanzhou Xinjing Pharmaceutical after three days, we will start contacting the second pharmaceutical company."

"Okay." Li Changhua also felt that three days was very suitable.

Now Changhua Pharmaceutical's output has reached a bottleneck. Otherwise, Changhua Pharmaceutical would not be so eager to acquire pharmaceutical factories.

Therefore, Su Zhe could give Guanzhou Xinjing Pharmaceutical three days to consider, which was already the limit, and the time could not be longer.

If Zhan Xin has not made a decision and responded to Changhua Pharmaceutical after three days, then Changhua Pharmaceutical will give up the acquisition of Guanzhou Xinjing Pharmaceutical and choose a second pharmaceutical factory.

Su Zhe believes that Zhan Xin is also very aware of this, so three days is enough for Zhan Xin to make a decision.

If Zhan Xin has not replied after three days, it means that he does not want to transfer Guanzhou Xinjing Pharmaceutical yet, so there is no point in waiting anymore and it will only be a waste of time.

"How's the loan going?" Su Zhe continued to ask,

Now Changhua Pharmaceutical's funds are not that abundant, if it is to acquire Guanzhou Xinjing Pharmaceutical. Or acquire other pharmaceutical factories. Changhua Pharmaceutical is short of funds.

So if the acquisition is successful. You have to get a loan from a bank.

"We have been contacted, and the bank has also given a reply. They have a condition, and they will only agree to the loan if we agree." Li Changhua said.

"What conditions?" Su Zhe couldn't help but raise his eyebrows when he heard that there were conditions.

"If we are unable to repay the entire loan within five years, the bank has the right to exchange shares of Changhua Pharmaceutical." Li Changhua said: "As long as we agree to this condition, the loan can be prepared for us immediately."

It seems that banks are also very optimistic about Changhua Pharmaceutical.

Otherwise, he wouldn't have put forward this condition. This clearly shows that he is thinking about Changhua Pharmaceutical's shares.

"Promise them this condition." Su Zhe said without hesitation.

Su Zhe has absolute confidence that he can pay off all the loans within five years.

I believe that in less than a year, Changhua Pharmaceutical will have enough funds to pay off all the loans, so Su Zhe doesn't have to worry at all.

Although the profits of the medicines launched by Changhua Pharmaceutical are not large, they cannot sustain large sales and small profits but quick turnover.

Excluding production costs and transportation costs. In addition to taxes and other expenses, the profit from a piece of Thawing Spirit is 2 yuan. The profit from a tablet of Xingshen Pills or Mepilin is 0.8 yuan per tablet.

Now, the sales volume of Thiefoling per day is 2 million pieces, and the daily profit is 4 million. The total sales volume of Xingshen tablets and Mepilin in one day is 6 million tablets. The daily profit is 4.8 million.

Calculated in this way, Changhua Pharmaceutical's daily net profit can reach 8.8 million, which is 260.4 million per month, and the net profit for a year is nearly 3.2 billion.

In other words, Changhua Pharmaceutical's one-year net profit is more than enough to repay the loan, so Su Zhe and the others don't have to worry about this problem at all.

Moreover, this year's net profit of 3.2 billion is based on the premise that the sales volume of Thalysin and other drugs remains unchanged.

But this is impossible. The sales volume of Thawsling, Xingshen tablets, and Sleeping Pills will definitely increase with the increase in production, and will not remain unchanged.

In addition, this only counts the profits from three drugs such as Thiefoling, Xingshen tablets, and Mepilin. The profits from the blue elixir that is about to be launched have not yet been included in this.

What's more, in addition to the blue elixir, Changhua Pharmaceutical doesn't know how many new drugs will be launched in this year.

Therefore, the net profit of Changhua Pharmaceutical in the next year will not be as simple as 3.2 billion. Even if there are only four drugs: Thaws Ling, Mian Bi Ling, Xingshen Tablets, and Lanling Yao, then Changhua Pharmaceutical's net profit in the next year will be The net profit is more than 3.2 billion, and the net profit is at least doubled. This is still a conservative estimate.

Not to mention anything else, just acquiring Guanzhou Xinjing Pharmaceutical or other pharmaceutical factories can greatly increase the output of Changhua Pharmaceutical, and sales will also increase accordingly.

Therefore, Su Zhe didn't need to think much about agreeing to the loan condition, not to mention there were still 5 years left.

Given Changhua Pharmaceutical 5 years of development time, Su Zhe is confident that Changhua Pharmaceutical will become a giant, a pharmaceutical giant that can handle everything with ease.

"Okay, after I get back, I will contact them immediately and try to finalize the matter." Li Changhua replied.

Although Li Changhua does not have as much confidence as Su Zhe, there is really nothing difficult for Changhua Pharmaceutical to solve in five years to repay the bank loan.

Therefore, Li Changhua was very relaxed about this matter. He had nothing to worry about.

Su Zhe nodded and said no more.

Now all the preparations have been done, and we are just waiting for Zhan Xin's reply. As soon as he agrees to the acquisition, the next work can be carried out immediately.

On the other hand, if Zhan Xin refuses in the end, Changhua Pharmaceutical can also choose another target.

Although losing Guanzhou Xinjing Pharmaceutical is a bit of a pity for Su Zhe and others, it does not stop there and has little impact on Changhua Pharmaceutical.

In the acquisition list, there are two companies as large as Guanzhou Xinjing Pharmaceutical, which are also very suitable for Changhua Pharmaceutical.

It's just that Guanzhou Xinjing Pharmaceutical has 50,000 acres more Chinese medicinal material planting base than the other two pharmaceutical companies, so Su Zhe and the others set Guanzhou Xinjing Pharmaceutical as their first acquisition target.

However, Guanzhou Xinjing Pharmaceutical's Chinese herbal medicine planting base is not so important to Changhua Pharmaceutical that it must be acquired.

Because as long as Changhua Pharmaceutical wants a Chinese herbal medicine planting base, it can purchase it from others, or it can build it by itself, but relatively speaking, it will be more troublesome and time-consuming.

However, Changhua Pharmaceutical currently does not need a planting base so urgently. Regarding the Chinese herbal medicine planting base, Changhua Pharmaceutical has decided to have a strategy that must be owned, but not immediately.

Therefore, compared with other pharmaceutical companies, the advantages that Guanzhou Xinjing Pharmaceutical has are actually not that big.

Therefore, there are actually many targets that Changhua Pharmaceutical can choose from. (To be continued...)

...

... ()